A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Immunogenicity of Test Pertuzumab (ZRC-3277, Cadila Healthcare Ltd.,)
Clinical trial NCT05283837 · COMPLETED
Trial details
- NCT number
- NCT05283837
- Sponsor
- Zydus Lifesciences Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-26
- Primary completion
- 2023-09-06
- Enrollment
- 268
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.